Media

The Biotechnology Industry Organization (BIO) today announced that it will showcase a series of unique sessions at this year’s Livestock Biotech Summit...
Sessions to focus on the FDA Breakthrough Therapy Designation Process, IPO Market, and BioCentury’s Back to School issue

Press Releases

Jun 13 2001
PHILADELPHIA, June 13, 2001 – The Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) have awarded the Biotechnology...
Jun 13 2001
WASHINGTON, D.C. (June 13, 2001) – Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) issued the following...
Jun 12 2001
BIO 2001 TO HOLD THIRD ANNUAL INTERNATIONAL INVESTOR & PARTNERING FORUM San Diego, Calif. (June 12, 2001) – The Biotechnology Industry Organization is...
Jun 11 2001
Washington, D.C. (June 11, 2001) – The Biotechnology Industry Organization (BIO) annual international conference and exhibition will feature a diverse group of...
Jun 4 2001
WASHINGTON, D.C. (June 4, 2001) – Millennium Pharmaceuticals, Inc. is conducting a congressional breakfast briefing on biotechnology on June 6, at 8:30 a.m. in...
May 31 2001
WASHINGTON, D.C. (May 31, 2001) – Advance media registration for BIO 2001, recommended for all reporters and editors and required for freelance journalists,...
May 23 2001
WASHINGTON, D.C. (May 23, 2001) – Advance media registration for BIO 2001, recommended for all reporters and editors and required for freelance journalists,...
May 23 2001
Premier Event Unites Investors and Biotechnology Entrepreneurs Washington, D.C. (May 23, 2001) – The Biotechnology Industry Organization (BIO) will host its...
May 22 2001
Washington, D.C. (May 22, 2001) – Bernice Welles, M.D., will speak on behalf of the Biotechnology Industry Organization Wednesday at a Senate hearing to...


Biotechnology News

September 17, 2014

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics...

September 17, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--Dr. Fanara will describe how KineMed’s biomarkers can be used to monitor disease progression and treatment response in...

September 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral has been awarded a Phase II SBIR contract from the National Cancer Institute to develop and deploy an advanced, automated...

September 17, 2014

ROCKLAND, Mass,--(BUSINESS WIRE)--EMD Serono, Inc.and Sutro Biopharma today announced a collaboration and license agreement to develop antibody drug conjugates (ADCs).

September 17, 2014

YAVNE, Israel--(BUSINESS WIRE)--Avraham Pharmaceuticals Raises $4.5 Million in Additional Investment Led by Yissum. The capital is intended for the on-going Phase 2b...